Medical Affairs Director at a large pharmaceutical company was looking to create an operating model for the company-wide transition of products in their late-lifecycle portfolio. This company required a Global Medical Affairs (GMA)-owned, adaptable, and modular framework that integrates with all business functions and leverages industry best practices.
Vynamic leveraged deep expertise in organizational change to create a business case for a new model in Medical Affairs and identified the core team as well as their roles and responsibilities. We also incorporated our understanding of current industry best practices through both an external peer benchmark and an internal company analysis. Vynamic then put the designed cross-functional operating model through a formal workshop with stakeholders to refine and rollout a Playbook. Lastly, Vynamic developed the key tools and training materials across the organization to maximize understanding.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Jump to a slide with the slide dots.
A top 10 life sciences firm drove $300M impact via enterprise-wide transformation, PMO scaling & strategy to tackle the patent cliff.
Read moreVynamic helped a global biopharma firm rapidly transform its Commercial & Medical model, achieving 97% of key changes and enabling strategic growth.
Read moreVynamic enabled omnichannel marketing, AI-driven sales, and governance, boosting HCP engagement, consumer reach, and sales impact.
Read more